Diversion Control

Diversion Control is a regulatory framework within controlled substance policy that constitutes the systematic monitoring, prevention, and interdiction of legally manufactured pharmaceuticals from entering illicit channels, distinguishing it from broader drug control strategies by its focus on the unauthorized transfer of substances within legitimate supply chains.

95

Publications

3.3K

Citations

283

Authors

142

Institutions

Publications per year

2017–2026

22

Authors

283

  1. BO
    Brian O’Neal

    The University of Kansas Health System, United States

    7 publications · 117 citations

    7

    h-index

  2. JS
    Jerry Siegel

    The Ohio State University Wexner Medical Center, United States

    4 publications · 62 citations

    4

    h-index

  3. KL
    Kenneth L. McCall

    University of New England, United States

    3 publications · 42 citations

    3

    h-index

  4. BS
    Brooke S. G. Molina

    University of Pittsburgh, United States

    2 publications · 42 citations

    3

    h-index

  5. RA
    Rachel A. Lindstrom

    University of Pittsburgh, United States

    2 publications · 42 citations

    3

    h-index

1–5 of 283

Venues

  1. Hospital Pharmacy

    6 publications · 83 citations

    6

    h-index

  2. International Journal of Drug Policy

    4 publications · 86 citations

    4

    h-index

  3. PubMed

    Repository · 4 publications · 78 citations

    4

    h-index

  4. Journal of Drug Issues

    JDI · 4 publications · 103 citations

    4

    h-index

  5. Substance Use & Misuse

    4 publications · 254 citations

    4

    h-index

1–5